Erratum to: Long-acting methylphenidate formulations in the treatment of attention-deficit/hyperactivity disorder: a systematic review of head-to-head studies

Documenti analoghi

• Long-acting methylphenidate formulations in the treatment of attention-deficit/hyperactivity disorder: a systematic review of head-to-head studies
  di: Coghill, David, et al.
  Pubblicazione: (2013)
• Molecular genetics of attention-deficit/hyperactivity disorder: an overview
  di: Banaschewski, Tobias, et al.
  Pubblicazione: (2010)
• Cognitive Function of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder in a 2-Year Open-Label Study of Lisdexamfetamine Dimesylate
  di: Coghill, David R., et al.
  Pubblicazione: (2018)
• Systematic review of quality of life and functional outcomes in randomized placebo-controlled studies of medications for attention-deficit/hyperactivity disorder
  di: Coghill, David R., et al.
  Pubblicazione: (2017)
• Amfetamine and methylphenidate medications for attention-deficit/hyperactivity disorder: complementary treatment options
  di: Hodgkins, Paul, et al.
  Pubblicazione: (2012)